.ANALYSIS EMPHASIZE.16 Oct 2024. In the NIAGARA hearing, the enhancement of perioperative durvalumab to standard treatment for muscle-invasive bladder cancer cells enhanced event-free as well as in general survival, denoting a brand-new treatment option for this disorder.